A 5-year Superion® IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Study Purpose

To compile real-world outcomes of the Superion® IDS in routine clinical practice.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.

Searching Both is inclusive of interventional and observational studies.

Eligible Ages 45 Years and Over
Gender All
More Inclusion & Exclusion Criteria


Inclusion Criteria:

  • - 45 years of age or older when written informed consent is obtained - Persistent leg/buttock/groin pain, with or without back pain that is consistently relieved by flexion activities (example: sitting or bending over a shopping cart).
  • - Diagnosis of degenerative spinal stenosis of the lumbar spine, defined as the narrowing of the midline sagittal spinal canal (central) and/or narrowing between the facet superior articulating process (SAP), the posterior vertebral margin (lateral access), and the nerve root canal (foraminal).
  • - Subject signed a valid, IRB-approved informed consent form (ICF) provided in English.
  • - Subjects, who, in the opinion of the Clinical Investigator, are able to understand this clinical investigation, cooperate with the investigational procedures and are willing to return for all the required post-treatment follow-ups.
  • - Able to independently read and complete all questionnaires and assessments provided in English Key

    Exclusion Criteria:

    - Axial back pain only.
  • - Fixed motor deficit in lower extremity(ies) due to LSS.
- Has any pain-related diagnosis, medical/psychological condition or external factors that, in the investigator's medical judgment, might confound reporting of study outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in litigation, workmen's compensation, spinal tumor) - Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.


Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Boston Scientific Corporation
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

Roshini Jain
Principal Investigator Affiliation Boston Scientific Corporation
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Overall Status Recruiting
Countries United States

The disease, disorder, syndrome, illness, or injury that is being studied.

Lumbar Spinal Stenosis
Additional Details

To compile real-world outcomes of the Superion® IDS in routine clinical practice, when used according to the applicable Directions for Use

Arms & Interventions


Experimental: Superion® IDS device

Superion® Indirect Decompression System (IDS)


Device: - Superion® IDS device

The Superion® IDS is a minimally-invasive spinal implant that treats LSS symptoms by limiting extension at the symptomatic level that compresses the neural elements and is designed for percutaneous surgical placement.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Boston Scientific Clinical Research, Valencia, California




Boston Scientific Clinical Research

Valencia, California, 91355

Site Contact

Boston Scientific

[email protected]